resveratrol has been researched along with Oculopharyngeal Dystrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abu-Baker, A; Brais, B; Catoire, H; Holbert, S; NĂ©ri, C; Parker, JA; Pasco, MY; Rouleau, GA; Tourette, C | 1 |
1 other study(ies) available for resveratrol and Oculopharyngeal Dystrophy
Article | Year |
---|---|
Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1.
Topics: Acetylation; AMP-Activated Protein Kinases; Animals; Animals, Genetically Modified; Benzamides; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cell Survival; Chlorocebus aethiops; COS Cells; Forkhead Transcription Factors; Gene Expression Regulation; Genes, Reporter; Histones; Humans; Multienzyme Complexes; Muscles; Muscular Dystrophy, Oculopharyngeal; Naphthols; Peptide Initiation Factors; Peptides; Protein Serine-Threonine Kinases; Resveratrol; RNA-Binding Proteins; Sirtuins; Stilbenes; Transcription Factors | 2008 |